48 Biggest Movers From Yesterday

Gainers

  • Carver Bancorp, Inc. CARV shares climbed 201.37 percent to close at $11.00 on Thursday.
  • Eiger BioPharmaceuticals, Inc. EIGR shares rose 41.77 percent to close at $16.80.
  • OptimumBank Holdings, Inc. OPHC jumped 35.28 percent to close at $6.25 on Thursday.
  • Pluralsight, Inc. PS gained 33.33 percent to close at $20.00. Pluralsight priced its IPO at $15 per share.
  • NL Industries, Inc. NL surged 26.67 percent to close at $9.50.
  • Seadrill Limited SDRL shares rose 26.09 percent to close at $0.58.
  • Audentes Therapeutics, Inc. BOLD gained 21.91 percent to close at $41.39.
  • Evolus, Inc. EOLS shares climbed 20.93 percent to close at $12.94 on Thursday.
  • Loxo Oncology, Inc. LOXO gained 20.09 percent to close at $167.53. The biopharmaceutical company that focuses on medicines for patients with genetically defined cancers said its oral presentation of LOXO-292 was selected for the "Best of ASCO" program.
  • Essendant Inc. ESND jumped 18.77 percent to close at $13.10. Essendant confirmed receipt of unsolicited proposal from Staples of $11.50 per share in cash.
  • Baozun Inc. BZUN shares rose 18.75 percent to close at $53.51 after reporting Q1 results.
  • Bright Scholar Education Holdings Limited BEDU gained 17.71 percent to close at $18.54.
  • Ultra Petroleum Corp. UPL gained 17.65 percent to close at $2.40.
  • World Wrestling Entertainment, Inc. WWE shares surged 15.42 percent to close at $50.31. The company's "Smackdown Live" may not be renewed at NBCUniversal network and the company's "Monday Night Raw" program could be worth three times its current value elsewhere, according to a report for The Hollywood Reporter.
  • Black Box Corporation BBOX gained 14.29 percent to close at $2.60.
  • Drive Shack Inc. DS shares jumped 14.17 percent to close at $6.77 on Thursday.
  • Minerva Neurosciences Inc NERV gained 13.85 percent to close at $7.40 after Journal of Clinical Psychiatry published positive results of cognitive performance from Phase 2B trial of roluperidone in schizophrenia patients.
  • CRISPR Therapeutics AG CRSP gained 13.44 percent to close at $65.40 on Thursday.
  • Halcón Resources Corporation HK climbed 13.18 percent to close at $5.58.
  • iPic Entertainment Inc. IPIC shares rose 12.54 percent to close at $9.003 on Thursday.
  • Spectrum Pharmaceuticals, Inc. SPPI rose 12.11 percent to close at $20.00 after the company issued further details on Phase 3 ADVANCE study of ROLONTIS.
  • Blink Charging Co BLNK gained 11.4 percent to close at $8.01 on Thursday after surging 31.68 percent on Wednesday.
  • Williams Partners L.P. WPZ shares rose 7.99 percent to close at $41.49 after The Williams Companies, Inc. WMB announced agreement to acquire all public equity of Williams Partners in a $10.5 billion deal.
  • Diana Containerships Inc. DCIX rose 7.74 percent to close at $1.67 after the company announced the sale of Post-Panamax Container Vessel for $21 million.
  • Endocyte, Inc. ECYT gained 7.56 percent to close at $13.51 after the company announced presentation of Phase 2 data from prostate cancer trial of 177Lu-PSMA-617 at the 2018 ASCO Annual Meeting.


Losers

  • Jounce Therapeutics, Inc. JNCE shares declined 35.2 percent to close at $11.45 on Thursday. Abstract of the Phase 1/2 ICONIC trial that evaluated JTX-2011 monotherapy as well as in combination with nivolumab showed that the company has met its target enrolment in its combination cohorts across four solid tumor types, namely gastric cancer, triple-negative breast cancer, head and neck squamous cell cancer and non-small cell lung cancer.
  • Syndax Pharmaceuticals, Inc. SNDX dipped 22.57 percent to close at $8.61 after the company issued updated results from Phase 2 ENCORE trial of entinostat in combo with KEYTRUDA.
  • Legacy Reserves LP LGCY shares fell 20.31 percent to close at $7.69.
  • Inspired Entertainment, Inc. INSE dropped 15.38 percent to close at $5.50.
  • China Internet Nationwide Financial Services Inc. CIFS dipped 13.88 percent to close at $24.82.
  • Dynavax Technologies Corporation DVAX declined 13.7 percent to close at $16.70. Dynavax announced that data will be presented from its ongoing Phase 1b/2 study investigating SD-101 in combination with KEYTRUDA® (pembrolizumab) at the 2018 ASCO Annual Meeting.
  • J. C. Penney Company, Inc. JCP fell 12.38 percent to close at $2.69 after the company reported downbeat Q1 results and lowered its FY2018 guidance.
  • Turtle Beach Corporation HEAR dipped 12.06 percent to close at $16.33.
  • Boxlight Corporation BOXL fell 11.99 percent to close at $8.66 on Thursday.
  • KEMET Corporation KEM dropped 11.95 percent to close at $18.65 following Q4 earnings.
  • HUYA Inc. HUYA shares fell 11.11 percent to close at $20.00 on Thursday.
  • Molecular Templates, Inc. MTEM shares dropped 10.71 percent to close at $7.34.
  • PetIQ, Inc. PETQ shares fell 9.92 percent to close at $18.25
  • Teekay Corporation TK declined 9.89 percent to close at $8.11 following Q1 earnings.
  • Flowers Foods, Inc. FLO dropped 9.53 percent to close at $19.56 after reporting Q1 results.
  • Tuniu Corporation TOUR fell 8.95 percent to close at $6.82 on Thursday.
  • Jack in the Box Inc. JACK fell 8.3 percent to close at $83.79 after the company reported downbeat results for its second quarter. Comps were down 0.1 percent in the quarter. The company sees third-quarter comps coming in flat to up 1 percent.
  • Aircastle Limited AYR fell 7.97 percent to close at $21.12 after announcing 7.9 million secondary offering of common shares.
  • Children's Place, Inc. PLCE shares declined 7.95 percent to close at $127.025 after reporting downbeat results for its first quarter.
  • Nektar Therapeutics NKTR fell 7.66 percent to close at $79.23. Nektar Therapeutics announced that six abstracts accepted for presentation at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.
  • NetEase, Inc. NTES dropped 7.46 percent to close at $246.16 after reporting Q1 results.
  • Blueprint Medicines Corporation BPMC dropped 5.19 percent to close at $81.90 as the company reported 2 data presentations supporting plans for rapid development of Avapritinib.
  • Cisco Systems, Inc. CSCO fell 3.76 percent to close at $43.46. Cisco reported better-than-expected results for its third quarter. The company sees fourth quarter earnings in the range of 68 cents-70 cents with sales growth of 4-6 percent.
Posted In: EnergyLosersMovers From YesterdayOil & Gas Exploration & ProductionTop GainersYesterday's GainersNewsMovers & ShakersPre-Market OutlookMarketsMoversTrading Ideas